Search for: "May v. Board of Directors" Results 301 - 320 of 4,822
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Aug 2010, 8:00 am by J Robert Brown Jr.
Finally, access to board documents may be further limited by the need to protect confidential board communications. [read post]
18 Jul 2023, 6:30 am
Boards and their advisors seeking to navigate the culture wars and their often conflicting pressures from a variety of stakeholders and outside groups may find some comfort and guidance in this recent decision from the Delaware Chancery Court in Simeone v. [read post]
18 Jul 2023, 6:30 am
Boards and their advisors seeking to navigate the culture wars and their often conflicting pressures from a variety of stakeholders and outside groups may find some comfort and guidance in this recent decision from the Delaware Chancery Court in Simeone v. [read post]
Rejecting the director defendant claims that the fiduciary duty claims were not ripe, the Court stated that Healthways’ stockholders may presently be “suffering a distinct injury” from the deterrent effect of the “proxy put” and the fact that the dissident directors are non-continuing directors under the “proxy put. [read post]
14 Dec 2007, 6:16 am
"This may be the first sentencing decision since the mid 1980s that actually talks about justice, that seems to have some blood in it," said Graham Boyd, director of the ACLU's drug law reform project. [read post]
23 Jul 2024, 1:11 pm by Kevin LaCroix
While reliance on management alone to address compliance risks is insufficient to address board-level oversight duties, the extent to which reliance on management may be sufficient depends on the context. [read post]
28 Aug 2017, 7:31 am by Lev Martyniuk
That is, the duty to evaluate a derivative action claim by the board of directors under Delaware case law, Zapata v. [read post]
28 Aug 2017, 7:31 am by Lev Martyniuk
That is, the duty to evaluate a derivative action claim by the board of directors under Delaware case law, Zapata v. [read post]
7 Mar 2023, 2:01 pm by Kevin LaCroix
At the same time, the board terminated Fairhurst with cause based on a further allegation of misconduct. [read post]
16 Dec 2022, 4:15 am by Emer Simic
The appointment of USPTO Director Kathi Vidal in April 2022 and her introduction of interim guidance in June 2022 has spurred changes at the Patent Trial and Appeal Board (PTAB) that may result in an increase in instituted inter partes reviews (IPRs) due to a dramatic decline in discretionary denials. [read post]
16 Dec 2022, 4:15 am by Emer Simic
The appointment of USPTO Director Kathi Vidal in April 2022 and her introduction of interim guidance in June 2022 has spurred changes at the Patent Trial and Appeal Board (PTAB) that may result in an increase in instituted inter partes reviews (IPRs) due to a dramatic decline in discretionary denials. [read post]
28 Mar 2018, 4:03 pm by Lawrence B. Ebert
The Board,acting as the delegate of the PTO’s Director under 37C.F.R. [read post]